Medical Properties Trust (MPT) Cash & Equivalents (2009 - 2026)

Medical Properties Trust (MPT) has reported Cash & Equivalents for 18 consecutive years, with $425.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash & Equivalents fell 36.89% year-over-year to $425.0 million; the TTM figure through Mar 2026 stood at $425.0 million (down 36.89% YoY), while the FY2025 annual figure was $540.9 million, up 62.75% from the prior year.
• Cash & Equivalents eased to $425.0 million in Q1 2026 per MPT's latest filing, from $540.9 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $673.5 million in Q1 2025 and bottomed at $224.3 million in Q1 2024.
• Historically, Cash & Equivalents has averaged $367.2 million across 5 years, with a median of $324.0 million in 2023.
• Annual changes were most pronounced in 2022 — Cash & Equivalents plunged 66.68% — and 2025, when it jumped 200.21%.
• Medical Properties Trust's Cash & Equivalents stood at $235.7 million in 2022, then advanced by 6.09% to $250.0 million in 2023, then surged by 32.93% to $332.3 million in 2024, then soared by 62.75% to $540.9 million in 2025, then dropped by 21.42% to $425.0 million in 2026.
• Business Quant data shows MPT's Cash & Equivalents at $425.0 million in Q1 2026, $540.9 million in Q4 2025, and $396.6 million in Q3 2025.